These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 4700275)

  • 21. Elevated flagellin-specific immunoglobulins in Crohn's disease.
    Sitaraman SV; Klapproth JM; Moore DA; Landers C; Targan S; Williams IR; Gewirtz AT
    Am J Physiol Gastrointest Liver Physiol; 2005 Feb; 288(2):G403-6. PubMed ID: 15388489
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum inhibitors of leukocyte chemotaxis in Crohn's disease and ulcerative colitis.
    Rhodes JM; Potter BJ; Brown DJ; Jewell DP
    Gastroenterology; 1982 Jun; 82(6):1327-34. PubMed ID: 6978274
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Anti-Saccharomyces cerevisiae antibodies in patients with Crohn's disease].
    Barta Z; Csípö I; Antal-Szalmás P; Sipka S; Szabó G; Szegedi G
    Orv Hetil; 2001 Oct; 142(42):2303-7. PubMed ID: 11760647
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A study of lymphocyte function in Crohn's disease using the mitotic index.
    Cave D; Brooke BN
    Br J Surg; 1973 Apr; 60(4):319. PubMed ID: 4700276
    [No Abstract]   [Full Text] [Related]  

  • 25. Pathogenesis of Crohn's disease.
    Przemioslo RT; Ciclitira PJ
    QJM; 1995 Aug; 88(8):525-7. PubMed ID: 7648238
    [No Abstract]   [Full Text] [Related]  

  • 26. [Role of immune reactions in the pathogenesis of ulcerative colitis and Crohn's disease].
    Mackiewicz S
    Przegl Lek; 1973; 30(10):838-40. PubMed ID: 4770505
    [No Abstract]   [Full Text] [Related]  

  • 27. Delayed hypersensitivity in Crohn's disease.
    Dykes PW
    Proc R Soc Med; 1970 Sep; 63(9):906-8. PubMed ID: 5477069
    [No Abstract]   [Full Text] [Related]  

  • 28. Suppression of immunoglobulin synthesis by lymphocyte subpopulations in patients with Crohn's disease.
    James SP; Neckers LM; Graeff AS; Cossman J; Balch CM; Strober W
    Gastroenterology; 1984 Jun; 86(6):1510-8. PubMed ID: 6232165
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The dyspeptic macrophage 30 years later: an update in the pathogenesis of Crohn's disease.
    Caprilli R; Frieri G
    Dig Liver Dis; 2009 Feb; 41(2):166-8. PubMed ID: 19026604
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Studies of the etiology of Crohn's disease using athymic nude mice.
    Das KM; Valenzuela I; Williams SE; Soeiro R; Kadish AS; Baum SG
    Gastroenterology; 1983 Feb; 84(2):364-74. PubMed ID: 6293908
    [TBL] [Abstract][Full Text] [Related]  

  • 31. IgG antibodies against common gut bacteria are more diagnostic for Crohn's disease than IgG against mannan or flagellin.
    Adams RJ; Heazlewood SP; Gilshenan KS; O'Brien M; McGuckin MA; Florin TH
    Am J Gastroenterol; 2008 Feb; 103(2):386-96. PubMed ID: 17924999
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Circulating immune complexes in ulcerative colitis and Crohn's disease.
    Jewell DP; Maclennan IC; Truelove SC
    Gut; 1972 Oct; 13(10):839-40. PubMed ID: 5087080
    [No Abstract]   [Full Text] [Related]  

  • 33. Isolation of Helicobacter pylori from the intestinal mucosa of patients with Crohn's disease.
    Oliveira AG; Rocha GA; Rocha AM; Sanna Md; Moura SB; Dani R; Marinho FP; Moreira LS; Ferrari Mde L; Castro LP; Queiroz DM
    Helicobacter; 2006 Feb; 11(1):2-9. PubMed ID: 16423084
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The level of neopterin in blood serum as one of the possible prognostic markers of Crohn's disease activity.
    Konecný M; Ehrmann J; Bartek J; Hermanová Z; Krc I
    Acta Univ Palacki Olomuc Fac Med; 1996; 140():47-8. PubMed ID: 9431690
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impaired innate immunity in Crohn's disease.
    Comalada M; Peppelenbosch MP
    Trends Mol Med; 2006 Sep; 12(9):397-9. PubMed ID: 16890491
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Presence of Z-DNA specific antibodies in Crohn's disease, polyradiculoneuritis and amyotrophic lateral sclerosis.
    Allinquant B; Malfoy B; Schuller E; Leng M
    Clin Exp Immunol; 1984 Oct; 58(1):29-36. PubMed ID: 6332695
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reduced suppressor cell activity in intestinal lymphocytes from patients with Crohn's disease.
    Goodacre RL; Bienenstock J
    Gastroenterology; 1982 Apr; 82(4):653-8. PubMed ID: 7060886
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunoglobulin studies in children with inflammatory bowel disease.
    Gryboski JD; Buie T
    Ann Allergy; 1994 Jun; 72(6):525-7. PubMed ID: 8203795
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Serum immunoglobulin concentrations in Crohn's disease. Clinical relevance and comparison with lipid-A-antibody titers (author's transl)].
    Kruis W; Paulus W; Fateh-Moghadam A; Schüssler P; Eisenburg J
    Z Gastroenterol; 1981 Jun; 19(6):276-83. PubMed ID: 7257484
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Current immunological aspects of Crohn's disease].
    Louis E; Belaiche J; Gast P; Delwaide J
    Rev Med Liege; 1991 Jan; 46(1):2-11. PubMed ID: 2011677
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.